Cargando…
Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD), which is in parallel with the obesity epidemic, accounts for a large amount of all chronic liver disease. Jiang Zhi Granule (JZG), a clinically used herbal formula, is developed in accordance with traditional Chinese medicine (TCM) pathogenesis for treating...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135841/ https://www.ncbi.nlm.nih.gov/pubmed/30209324 http://dx.doi.org/10.1038/s41598-018-31708-8 |
_version_ | 1783354886610485248 |
---|---|
author | Zheng, Yiyuan Wang, Miao Zheng, Peiyong Tang, Xudong Ji, Guang |
author_facet | Zheng, Yiyuan Wang, Miao Zheng, Peiyong Tang, Xudong Ji, Guang |
author_sort | Zheng, Yiyuan |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD), which is in parallel with the obesity epidemic, accounts for a large amount of all chronic liver disease. Jiang Zhi Granule (JZG), a clinically used herbal formula, is developed in accordance with traditional Chinese medicine (TCM) pathogenesis for treating patients with NAFLD. In previous studies, the anti-steatotic effects of JZG against NAFLD have been demonstrated, and in this study, a systems pharmacology approach was used to explore the pharmacological mechanisms of JZG by predicting the active compounds within the herbal formula and their corresponding therapeutic targets. Its therapeutic efficacy was confirmed in the beginning of this study, and JZG was shown to significantly improve hepatic dysfunction and lipid droplet accumulation in PA-treated hepatocytes. Systems pharmacology was then performed to identify the active compounds in as well as to predict the therapeutic targets of this Chinese herbal prescription. Enrichment analyses indicated that the mechanisms of the anti-steatotic effects of JZG against NAFLD might be associated with lipid droplet degradation via autophagy, and a series of in vitro and in vivo validation experiments was subsequently performed to confirm that JZG could activate autophagy though the mTOR signalling to improve NAFLD. |
format | Online Article Text |
id | pubmed-6135841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61358412018-09-15 Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease Zheng, Yiyuan Wang, Miao Zheng, Peiyong Tang, Xudong Ji, Guang Sci Rep Article Non-alcoholic fatty liver disease (NAFLD), which is in parallel with the obesity epidemic, accounts for a large amount of all chronic liver disease. Jiang Zhi Granule (JZG), a clinically used herbal formula, is developed in accordance with traditional Chinese medicine (TCM) pathogenesis for treating patients with NAFLD. In previous studies, the anti-steatotic effects of JZG against NAFLD have been demonstrated, and in this study, a systems pharmacology approach was used to explore the pharmacological mechanisms of JZG by predicting the active compounds within the herbal formula and their corresponding therapeutic targets. Its therapeutic efficacy was confirmed in the beginning of this study, and JZG was shown to significantly improve hepatic dysfunction and lipid droplet accumulation in PA-treated hepatocytes. Systems pharmacology was then performed to identify the active compounds in as well as to predict the therapeutic targets of this Chinese herbal prescription. Enrichment analyses indicated that the mechanisms of the anti-steatotic effects of JZG against NAFLD might be associated with lipid droplet degradation via autophagy, and a series of in vitro and in vivo validation experiments was subsequently performed to confirm that JZG could activate autophagy though the mTOR signalling to improve NAFLD. Nature Publishing Group UK 2018-09-12 /pmc/articles/PMC6135841/ /pubmed/30209324 http://dx.doi.org/10.1038/s41598-018-31708-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Zheng, Yiyuan Wang, Miao Zheng, Peiyong Tang, Xudong Ji, Guang Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease |
title | Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease |
title_full | Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease |
title_fullStr | Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease |
title_full_unstemmed | Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease |
title_short | Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease |
title_sort | systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of jiang zhi granule on non-alcoholic fatty liver disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135841/ https://www.ncbi.nlm.nih.gov/pubmed/30209324 http://dx.doi.org/10.1038/s41598-018-31708-8 |
work_keys_str_mv | AT zhengyiyuan systemspharmacologybasedexplorationrevealsmechanismsofantisteatoticeffectsofjiangzhigranuleonnonalcoholicfattyliverdisease AT wangmiao systemspharmacologybasedexplorationrevealsmechanismsofantisteatoticeffectsofjiangzhigranuleonnonalcoholicfattyliverdisease AT zhengpeiyong systemspharmacologybasedexplorationrevealsmechanismsofantisteatoticeffectsofjiangzhigranuleonnonalcoholicfattyliverdisease AT tangxudong systemspharmacologybasedexplorationrevealsmechanismsofantisteatoticeffectsofjiangzhigranuleonnonalcoholicfattyliverdisease AT jiguang systemspharmacologybasedexplorationrevealsmechanismsofantisteatoticeffectsofjiangzhigranuleonnonalcoholicfattyliverdisease |